“The moral I draw from this case and will never forget is that a hypothesis in relation to the causation of a child’s injuries must not be dismissed only because such causation would be highly unusual and that, where his history contains a demonstrably rare feature, that the possible nexus between that feature and his injuries must be the subject of specialist appraisal at an early stage.”
“28. … in some contexts a court or tribunal has to look at the facts more critically or more anxiously than in others before it can be satisfied to the requisite standard. The standard itself is, however, finite and unvarying. Situations which make such heightened examination necessary may be the inherent unlikelihood of the occurrence taking place (Lord Hoffmann's example of the animal seen in Regent's Park), the seriousness of the allegation to be proved or, in some cases, the consequences which could follow from acceptance of proof of the relevant fact. The seriousness of the allegation requires no elaboration: a tribunal of fact will look closely into the facts grounding an allegation of fraud before accepting that it has been established. The seriousness of consequences is another facet of the same proposition: if it is alleged that a bank manager has committed a minor peculation, that could entail very serious consequences for his career, so making it the less likely that he would risk doing such a thing. These are all matters of ordinary experience, requiring the application of good sense on the part of those who have to decide such issues. They do not require a different standard of proof or a specially cogent standard of evidence, merely appropriately careful consideration by the tribunal before it is satisfied of the matter which has to be established.”
“a picture of health” • Dr Ayoub, in written reply to questions in April 2017: “That C suffered from metabolic bone disease is beyond certain.” [E378] • Dr Allgrove, in reply to Mr Feehan: for a paediatrician to describe a child with so many fractures to normal bones as ‘a picture of health’six days before admission is “unthinkable”
“I’ve not seen any high-risk family. I don’t believe any case of fractures I’ve seen has been as a result of real physical child abuse, that it’s metabolic.”
“A factor that has not been considered by Professor Bishop is the supply of calcium. It has long been recognised that the inhibition of gastric acid production reduces calcium absorption. Fibre within the diet may also reduce calcium absorption. Used as a feed thickener specifically for reflux, locust bean gum safety in neonates and young infants has been reviewed (Meunier et al. 2014). However, this is not been done in the context of other medications such as Gaviscon or Ranitidine used in the treatment of gastro-oesophageal reflux. In the case of C it is to be noted that its use is not recommended in pre-term infants (ibid). Studies in vitro have shown that locust bean gum reduces the availability of materials such as calcium and iron and this is likely to be exacerbated by a reduction in gastric acid production (Bosscher et al. 2001). Professor Bishop excluded the diagnosis of Caffey’s disease because of the lack of associated clinical features. However, it is noteworthy that neither he nor indeed Dr Halliday included hypervitaminosis A in the differential diagnosis. Whilst I am not a radiologist, this is usually included in the textbook differential diagnosis of the characteristic exuberant periosteal hyperostosis. Furthermore, there are reports of hypervitaminosis A affecting the metaphyses of long bones. Vitamin A is rapidly absorbed and slowly cleared. It is stored in the liver. In excess, it is the only toxic substance known in rats to lead to spontaneous fractures. Although vitamin A toxicity has been known about for centuries and characterised since the 1940s, there remain large lacunae in knowledge. It is recognised that toxicity is seen at lower doses in the young and elderly, and that there may be other factors exacerbating toxicity. Some of these may be genetic (Hathcock et al., 1990). In vulnerable groups such as children toxicity has been reported with doses of the order of 1500IU/kg/d (ibid). The presentation of toxicity varies with the dose and duration of exposure, as well as the age of the individual exposed. C was noted to have irritability, failure to thrive, persisting, anaemia, and by inference, bone pain and tenderness. The Committee on Toxicity of the Food Standards Agency (CoT 2013) has recommended for infants, a Tolerable Upper Limit (TUL) for preformed vitamin A of 200µg RE/kg/day. Human breast milk contains circa 80µg RE/100ml; Cow & Gate Stage 1 55µg RE/100ml; human breast milk with fortifier contains 315µg RE/100ml (Cow & Gate; Reference). I am not a Neonatologist, and it is not possible accurately to calculate vitamin A intake in the SCBU from the available material, but it is to be noted that C received human breast milk with fortifier during this admission and after discharge until about the middle of April, when he was eight weeks old. At this time he was receiving 2500IU vitamin A in Dalivit and this was continued subsequently. Depending on the number of sachets of fortifier added to each 100ml of breast milk. It may be roughly calculated that he was receiving about fourfold the TUL and an amount of vitamin A that has been associated with toxicity in reported cases. It is noted that the Dalivit dose was increased in June 2014 and yet the radiological appearances of C’s bones were reported to have improved 5 months later. This may be accounted for by a number of factors. His growth meant that the dose of vitamin A per kg body weight was reduced. There may also have been maturation of changes in the liver. In addition, it is known that there is a potential antagonism between vitamins A and D. He was likely to have been born with a marked vitamin D deficiency and thus to have been more sensitive to vitamin A excess. As the vitamin D stores improved. He may have become more resistant to vitamin A. In addition, he was no longer taking any medication for reflux after discharge. As there is evidence that histamine has physiological effects on bone cells (both osteoclasts and osteoblasts) it is possible that histamine (H2) receptor antagonism may have played a role (perhaps idiosyncratically in C) in the effects on bone. This effect was removed when the ranitidine was stopped in June 2014.”